Pfizer Inc (PFE)
Pretax margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 8,023,000 | 3,904,000 | -4,163,000 | -1,791,000 | 1,058,000 | 10,418,000 | 22,771,000 | 31,949,000 | 34,729,000 | 33,325,000 | 32,160,000 | 27,322,000 | 23,955,000 | 20,306,000 | 14,646,000 | 11,990,000 | 10,192,000 | 8,506,000 | 17,057,000 | 17,245,000 |
| Revenue (ttm) | US$ in thousands | 63,627,000 | 60,113,000 | 55,643,000 | 55,094,000 | 58,497,000 | 68,538,000 | 77,944,000 | 92,952,000 | 100,331,000 | 99,879,000 | 101,335,000 | 92,570,000 | 81,491,000 | 69,337,000 | 57,374,000 | 50,198,000 | 47,644,000 | 48,648,000 | 49,197,000 | 50,660,000 |
| Pretax margin | 12.61% | 6.49% | -7.48% | -3.25% | 1.81% | 15.20% | 29.21% | 34.37% | 34.61% | 33.37% | 31.74% | 29.51% | 29.40% | 29.29% | 25.53% | 23.89% | 21.39% | 17.48% | 34.67% | 34.04% |
December 31, 2024 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $8,023,000K ÷ $63,627,000K
= 12.61%
Pfizer Inc's pretax margin has exhibited fluctuations over the period between March 31, 2020, and December 31, 2024. The pretax margin started at 34.04% in March 2020 and gradually increased to a peak of 34.61% by December 2022. However, there was a decline in the pretax margin in the subsequent periods, reaching a low of -7.48% in June 2024. Notably, the pretax margin recovered to 12.61% by December 2024. The trend indicates some volatility in Pfizer's ability to generate profits before taxes, with the company experiencing both highs and lows in its financial performance over the analyzed period.
Peer comparison
Dec 31, 2024